|
1
|
Ferreira M, Lanziotti L, Monteiro M,
Abuhadba G, Capotorto LF, Nolte L and Fearnot N: Superficial
femoral artery recanalization with self-expanding nitinol stents:
Long-term follow-up results. Eur J Vasc Endovasc Surg. 34:702–708.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krankenberg H, Schlüter M, Steinkamp HJ,
Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M,
Tepe G, et al: Nitinol stent implantation versus percutaneous
transluminal angioplasty in superficial femoral artery lesions up
to 10 cm in length: The femoral artery stenting trial (FAST).
Circulation. 116:285–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeller T, Tiefenbacher C, Steinkamp HJ,
Langhoff R, Wittenberg G, Schlüter M, Buergelin K, Rastan A,
Krumsdorf U, Sixt S, et al: Nitinol stent implantation in TASC A
and B superficial femoral artery lesions: The femoral artery
conformexx trial (FACT). J Endovasc Ther. 15:390–398. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schillinger M, Sabeti S, Dick P, Amighi J,
Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J and Minar E:
Sustained benefit at 2 years of primary femoropopliteal stenting
compared with balloon angioplasty with optional stenting.
Circulation. 115:2745–2749. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rocha-Singh KJ, Jaff MR, Crabtree TR,
Bloch DA and Ansel G; VIVA Physicians, Inc, : Performance goals and
endpoint assessments for clinical trials of femoropopliteal bare
nitinol stents in patients with symptomatic peripheral arterial
disease. Catheter Cardiovasc Interv. 69:910–919. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Norgren L, Hiatt WR, Dormandy JA, Nehler
MR, Harris KA, Fowkes FG; TASC II Working Group, ; Bell K,
Caporusso J, Durand-Zaleski I, et al: Inter-society consensus for
the management of peripheral arterial disease (TASCII). Eur J Vasc
Endovasc Surg. 33 (Suppl 1):S1–S75. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gur I, Lee W, Akopian G, Rowe VL, Weaver
FA and Katz SG: Clinical outcomes and implications of failed
infrainguinal endovascular stents. J Vasc Surg. 53:658–666. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Armstrong EJ, Saeed H, Alvandi B, Singh S,
Singh GD, Yeo KK, Anderson D, Westin GG, Dawson DL, Pevec WC and
Laird JR: Nitinol self-expanding stents vs. balloon angioplasty for
very long femoropopliteal lesions. J Endovasc Ther. 21:34–43. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schillinger M, Sabeti S, Loewe C, Dick P,
Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J and Minar E:
Balloon angioplasty versus implantation of nitinol stents in the
superficial femoral artery. N Engl J Med. 354:1879–1888. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Laird JR, Katzen BT, Scheinert D, Lammer
J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E,
et al: Nitinol stent implantation versus balloon angioplasty for
lesions in the superficial femoral artery and proximal popliteal
artery: Twelve-month results from the RESILIENT randomized trial.
Circ Cardiovasc Interv. 3:267–276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scheinert D, Laird JR Jr, Schröder M,
Steinkamp H, Balzer JO and Biamino G: Excimer laser-assisted
recanalization of long, chronic superficial femoral artery
occlusions. J Endovasc Ther. 8:156–166. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laird JR, Zeller T, Gray BH, Scheinert D,
Vranic M, Reiser C and Biamino G; LACI Investigators, : Limb
salvage following laser-assisted angioplasty for critical limb
ischemia: Results of the LACI multicenter trial. J Endovasc Ther.
13:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bosiers M, Peeters P, Elst FV, Vermassen
F, Maleux G, Fourneau I and Massin H: Excimer laser assisted
angioplasty for critical limb ischemia: Results of the LACI Belgium
study. Eur J Vasc Endovasc Surg. 29:613–619. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Serino F, Cao Y, Renzi C, Mascellari L,
Toscanella F, Raskovic D, Tempesta P, Bandiera G and Santini A:
Excimer laser ablation in the treatment of total chronic
obstructions in critical limb ischaemia in diabetic patients.
Sustained efficacy of plaque recanalisation in mid-term results.
Eur J Vasc Endovase Surg. 39:234–238. 2010. View Article : Google Scholar
|
|
15
|
Werk M, Langner S, Reinkensmeier B,
Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U and Ricke
J: Inhibition of restenosis in femoropopliteal arteries:
Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel
randomized pilot trial. Circulation. 118:1358–1365. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tepe G, Zeller T, Albrecht T, Heller S,
Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B
and Speck U: Local delivery of paclitaxel to inhibit restenosis
during angioplasty of the leg. N Engl J Med. 358:689–699. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ansel GM and Lumsden AB: Evolving
modalities for femoropopliteal interventions. J Endovasc Ther. 16
(Suppl 2):II82–II97. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grotti S, Liistro F, Angioli P, Ducci K,
Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G and
Bolognese L: Paclitaxel-eluting balloon vs standard angioplasty to
reduce restenosis in diabetic patients with in-stent restenosis of
the superficial femoral and proximal popliteal arteries: Three-year
results of the DEBATE-ISR study. J Endovasc Ther. 23:52–57. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Virga V, Stabile E, Biamino G, Salemme L,
Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A,
et al: Drug-eluting balloons for the treatment of the superficial
femoral artery in-stent restenosis: 2-year follow-up. JACC
Cardiovasc Interv. 7:411–415. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kokkinidis DG, Hossain P, Jawaid O,
Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR and Armstrong EJ:
Laser atherectomy combined with drug-coated balloon angioplasty is
associated with improved 1-year outcomes for treatment of
femoropopliteal in-stent restenosis. J Endovasc Ther. 25:81–88.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Van den Berg JC, Pedrotti M, Canevascini
R, Chimchila Chevili S, Giovannacci L and Rosso R: In-stent
restenosis: Mid-term results of debulking using excimer laser and
drug-eluting balloons: Sustained benefit? J Invasive Cardiol.
26:333–337. 2014.PubMed/NCBI
|
|
22
|
Sixt S, Carpio Cancino OG, Treszl A,
Beschorner U, Macharzina R, Rastan A, Krankenberg H, Neumann FJ and
Zeller T: Drug-coated balloon angioplasty after directional
atherectomy improves outcome in restenotic femoropopliteal
arteries. J Vasc Surg. 58:682–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rutherford RB, Baker JD, Ernst C, Johnston
KW, Porter JM, Ahn S and Jones DN: Recommended standards for
reports dealing with lower extremity ischemia: Revised version. J
Vasc Surg. 26:517–538. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Popma JJ, Tiroch K, Almonacid A, Cohen S,
Kandzari DE and Leon MB: A qualitative and quantitative
angiographic analysis of stent fracture late following
sirolimus-eluting stent implantation. Am J Cardiol. 103:923–929.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ranke C, Creutzig A and Alexander K:
Duplex scanning of the peripheral arteries: Correlation of the peak
velocity ratio with angiographic diameter reduction. Ultrasound Med
Biol. 18:433–440. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shammas NW, Shammas GA, Helou TJ,
Voelliger CM, Mrad L and Jerin M: Safety and 1-year
revascularization outcome of SilverHawk atherectomy in treating
in-stent restenosis of femoropopliteal arteries: A retrospective
review from a single center. Cardiovasc Revasc Med. 13:224–227.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dippel EJ, Makam P, Kovach R, George JC,
Patlola R, Metzger DC, Mena-Hurtado C, Beasley R, Soukas P,
Colon-Hernandez PJ, et al: Randomized controlled study of excimer
laser atherectomy for treatment of femoropopliteal in-stent
restenosis: Initial results from the EXCITE ISR trial (EXCImer
Laser Randomized Controlled Study for Treatment of FemoropopliTEal
In-Stent Restenosis). JACC Cardiovasc Interv. 8:92–101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez L, Chen A, Lin PH, Pisimisis G,
Barshes NR, Bechara CF and Kougias P: Latest recanalization
techniques for complex superficial femoral artery occlusions. J
Cardiovasc Surg (Torino). 53:487–494. 2012.PubMed/NCBI
|
|
29
|
Golomb BA, Dang TT and Criqui MH:
Peripheral arterial disease: Morbidity and mortality implications.
Circulation. 114:688–699. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He Y, Jiang Y, Wang J, Fan L, Li X and Hu
FB: Prevalence of peripheral arterial disease and its association
with smoking in a population-based study in Beijing, China. J Vasc
Surg. 44:333–338. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo Y, Li X, Li J, Wang X, Qiao Y, Hu D,
Merriam PA and Ma Y: Combined effects of smoking and peripheral
arterial disease on all-cause and cardiovascular disease mortality
in a Chinese male cohort. J Vasc Surg. 51:673–678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dormandy JA and Rutherford RB: Management
of peripheral arterial disease (PAD). TASC working group.
TransAtlantic inter-society consensus (TASC). J Vasc Surg.
31:S1–S296. 2000.PubMed/NCBI
|
|
33
|
Bosiers M, Torsello G, Gissler HM, Ruef J,
Müller-Hülsbeck S, Jahnke T, Peeters P, Daenens K, Lammer J, Schroë
H, et al: Nitinol stent implantation in long superficial femoral
artery lesions: 12-month results of the DURABILITY I study. J
Endovasc Ther. 16:261–269. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou W, Bush RL, Lin PH, Peden EK and
Lumsden AB: Laser atherectomy for lower extremity
revascularization: An adjunctive endovascular treatment option.
Vasc Endovascular Surg. 40:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sultan S, Tawfick W and Hynes N: Cool
excimer laser-assisted angioplasty (CELA) and tibial balloon
angioplasty (TBA) in management of infragenicular arterial
occlusion in critical lower limb ischemia (CLI). Vasc Endovascular
Surg. 47:179–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dave RM, Patlola R, Kollmeyer K, Bunch F,
Weinstock BS, Dippel E, Jaff MR, Popma J and Weissman N; CELLO
Investigators, : Excimer laser recanalization of femoropopliteal
lesions and 1-year patency: Results of the CELLO registry. J
Endovasc Ther. 16:665–675. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liistro F, Grotti S, Porto I, Angioli P,
Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G and
Bolognese L: Drug-eluting balloon in peripheral intervention for
the superficial femoral artery: The DEBATE-SFA randomized trial
(drug eluting balloon in peripheral intervention for the
superficial femoral artery). JACC Cardiovasc Interv. 6:1295–1302.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rosenfield K, Jafr MR, White CJ,
Rocha-Singh K, Mena-Hurtado C, Metzger DC, Brodmann M, Pilger E,
Zeller T, Krishnan P, et al: Trial of a paclitaxel-coated balloon
for femoropopliteal artery disease. N Engl J Med. 373:145–153.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tepe G, Laird J, Schneider P, Brodmann M,
Krishnan P, Micari A, Metzger C, Scheinert D, Zeller T, Cohen DJ,
et al: Drug-coated balloon versus standard percutaneous
transluminal angioplasty for the treatment of superficial femoral
and popliteal peripheral artery disease: 12-month results from the
IN.PACT SFA randomized trial. Circulation. 131:495–502. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McKinsey JF, Goldstein L, Khan HU, Graham
A, Rezeyat C, Morrissey NJ, Sambol E and Kent KC: Novel treatment
of patients with lower extremity ischemia: Use of percutaneous
atherectomy in 579 lesions. Ann Surg. 248:519–528. 2008.PubMed/NCBI
|
|
41
|
Wissgott C, Kamusella P, Lüdtke C and
Andresen R: Excimer laser atherectomy after unsuccessful
angioplasty of TASC C and D lesions in femoropopliteal arteries. J
Cardiovasc Surg (Torino). 54:359–365. 2013.PubMed/NCBI
|
|
42
|
Lüdtke CW, Scheer F, Kamusella P, Wissgott
C and Andresen R: Transpopliteal balloon-assisted excimer-laser
atherectomy for the treatment of chronic femoropopliteal
occlusions: Feasibility and initial results. Clin Med Insights
Cardiol. 8 (Suppl 2):S23–S28. 2014.
|
|
43
|
Sangiorgi G, Lauria G, Airoldi F, Godino
C, Politi L, Colombo A, Clerici G, Modena MG and Biondi-Zoccai G:
Retrograde popliteal access as bail-out strategy for challenging
occlusions of the superficial femoral artery: A multicenter
registry. Catheter Cardiovasc Interv. 79:1188–1193. 2012.
View Article : Google Scholar : PubMed/NCBI
|
